These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8117160)

  • 1. Climacteric symptoms and hormonal replacement therapy: a risk or an opportunity?
    Lindgren R
    Arch Gynecol Obstet; 1993; 253 Suppl():S45-9. PubMed ID: 8117160
    [No Abstract]   [Full Text] [Related]  

  • 2. [The current principles of the hormonal therapy of patients with the climacteric syndrome].
    Gudkova MA
    Akush Ginekol (Mosk); 1994; (2):7-11. PubMed ID: 8017586
    [No Abstract]   [Full Text] [Related]  

  • 3. [The climacteric and its hormonal treatment].
    Gvorgiev DB
    Akush Ginekol (Sofiia); 1993; 32(1):36-40. PubMed ID: 8172347
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy in climacteric. Varying research results on risks and benefits].
    Magnusson C; Persson I
    Lakartidningen; 1997 Mar; 94(13):1176-9. PubMed ID: 9148053
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen replacement and heart disease.
    Walsh BW
    Clin Obstet Gynecol; 1992 Dec; 35(4):894-900. PubMed ID: 1451372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen during and after climacteric--problems and possibilities for primary health care].
    Blivik J
    Lakartidningen; 2001 Mar; 98(10):1145-6. PubMed ID: 11301984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].
    MMW Fortschr Med; 2010 Jun; 152(24):18. PubMed ID: 20672580
    [No Abstract]   [Full Text] [Related]  

  • 9. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone replacement in patients at high risk for thromboses].
    Hiller F
    Internist (Berl); 1997 Oct; 38(10):999-1000. PubMed ID: 9432514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in AT-III following hormone therapy of females in the climacteric].
    Enzelsberger H; Heytmanek G; Kurz C; Metka M
    Gynakol Rundsch; 1989; 29 Suppl 2():422-4. PubMed ID: 2613068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors].
    Lauritzen C
    Zentralbl Gynakol; 1990; 112(17):1071-90. PubMed ID: 2264417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogens in menopause--therapy and prevention. I. Hormone substitution in climacteric and postmenopause].
    Wuttke W
    Internist (Berl); 1996 Apr; 37(4):402-5. PubMed ID: 8655280
    [No Abstract]   [Full Text] [Related]  

  • 14. Menopausal hormone replacement: not necessarily routine.
    Guinan ME
    J Med Assoc Ga; 1994 Apr; 83(4):205-8. PubMed ID: 8006547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
    Nilsson K
    Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal treatment for the climacteric: alleviation of symptoms and prevention of postmenopausal disease.
    te Velde ER; van Leusden HA
    Lancet; 1994 Mar; 343(8898):654-8. PubMed ID: 7906817
    [No Abstract]   [Full Text] [Related]  

  • 17. [More damage than gain].
    Glaeske G
    Kinderkrankenschwester; 2004 Apr; 23(4):144-5. PubMed ID: 16134646
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recommendations for estrogen and progestin replacement therapy in climacteric and postmenopause. 31. Professional Meeting of the Zurich Discussion Circle, October 2003].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):258-64. PubMed ID: 15459525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Climacteric symptoms. Hormone treatment relieves climacteric symptoms].
    Varhos G; Leijon K; Heimer G
    Vardfacket; 1991 Feb; 15(3):IX-X. PubMed ID: 2053401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.